Skip to main content
    • Mounjaro
    • Wegovy

    Mounjaro and Gallstones: The Risk and What to Watch For

    Can Mounjaro cause gallstones? How common they are, whether you can take it with gallstones or after gallbladder removal, and the warning signs to know.

    Jimah Alsaai MPharmJimah Alsaai MPharmSuperintendent Pharmacist
    GPhC 2232652
    Reviewed November 2026
    10 min read

    Start your free consultation with a GPhC-registered pharmacist.

    Begin consultation

    Short answer: Yes, Mounjaro (tirzepatide) can cause gallstones. The UK product information lists gallstones (cholelithiasis) as a common side effect in the weight-management trials, which means up to 1 in 10 people, and an inflamed gallbladder (cholecystitis) as uncommon, up to 1 in 100 (SmPC, section 4.8). In the pooled SURMOUNT-1, -2 and -3 trials, acute gallbladder problems affected 2.0% of people on tirzepatide and 1.6% of people on placebo, and the product information links them to greater weight loss. Losing weight quickly raises the risk of gallstones whatever causes it. Whether you can take Mounjaro with gallstones depends on whether they are causing problems now: we do not supply it to anyone with gallbladder problems right now, a past history is reviewed by the pharmacist, and the product information places no restriction on people whose gallbladder has been removed.

    This guide sets out what the Mounjaro and Wegovy product information, the NHS and the MHRA say about gallstones, as of November 2026: how common they are, why losing weight raises the risk, what our consultation asks, what changes after gallbladder removal, the symptoms to know and when to get urgent help.

    Can Mounjaro cause gallstones?

    Yes: gallstones are a listed side effect of Mounjaro, graded common in the weight-management trials, and the product information says the acute gallbladder events in those trials "were positively correlated with weight reduction". The grading is in section 4.8 of the Mounjaro KwikPen product information (text revised August 2026), which lists cholelithiasis (gallstones) as common and cholecystitis (an inflamed gallbladder) as uncommon for the weight-management trials.

    The figures behind the grading, counting everyone in the pooled SURMOUNT-1, -2 and -3 weight-management trials who had the medicine or placebo, are in the table below: any acute gallbladder disease was reported in 2.0% of people on tirzepatide and 1.6% on placebo, a difference of 0.4 percentage points, and the gallstone figure itself, 1.1%, sits at the bottom of the common band. SURMOUNT-1 ran for 72 weeks in 2,539 adults with a BMI of 30 or above, or 27 or above with a weight-related condition, on 5mg, 10mg or 15mg a week.

    Gallstones are also common in people who take no weight-loss medicine at all: the NHS says they affect more than 1 in 10 adults in the UK and often cause no symptoms, so many are found by chance on a scan for something else. A gallstone found during treatment is not always the medicine's doing.

    A Mounjaro KwikPen, 15mg
    A Mounjaro KwikPen, 15mg, the maximum dose. The gallbladder figures in this guide pool the weight-management trials, which tested 5mg, 10mg and 15mg.

    Gallbladder problems and Mounjaro: what the product information says

    EventHow commonWhat it means for you
    Gallstones (cholelithiasis)Common in the weight-management trials, up to 1 in 10 people: reported by 1.1% on tirzepatide and 1.0% on placebo in SURMOUNT-1, -2 and -3Most gallstones cause no symptoms. Tell us about any gallstones, now or in the past, in the health questions, and tell your pharmacist if they are found during treatment
    Inflamed gallbladder (cholecystitis)Uncommon, up to 1 in 100 people: 0.6% against 0.2% in the same trialsA sudden, sharp pain in the upper right of your tummy that does not go away within a few hours, sometimes with a high temperature. Stop your treatment and get urgent help
    Any acute gallbladder disease2.0% against 1.6% in the same trials, linked to greater weight lossLinked to how much weight people lost. Losing weight steadily, at the usual dose steps, is the NHS advice and ours
    Acute pancreatitis (an inflamed pancreas)Uncommon, up to 1 in 100 peopleA gallstone that blocks a duct is one cause of pancreatitis. Severe, persistent stomach pain spreading to your back needs urgent help, and Mounjaro is not restarted if pancreatitis is confirmed

    Why do weight loss injections raise the risk of gallstones?

    Losing weight quickly raises the risk of gallstones whatever causes it, and the Mounjaro product information links the gallbladder problems in its trials to greater weight loss. The NHS lists having lost weight quickly, its example being weight loss surgery, among the things that make gallstones more likely, and its acute cholecystitis page explains why: low-calorie rapid weight loss diets "can disrupt your bile chemistry and actually increase your risk of developing gallstones", so it advises a more gradual weight loss plan. The product information itself gives no mechanism, and we do not add one.

    The other NHS risk factors are worth knowing because many people starting treatment already have some of them: being over 40, being a woman, living with obesity, a diet high in fat and low in fibre, and a condition such as diabetes or Crohn's disease. Treatment brings weight loss, and the trials tied the gallbladder events to how much weight people lost, which is why the advice later in this guide is about the pace of it.

    Can you take Mounjaro if you have gallstones?

    It depends on whether your gallstones are causing problems now. Our first consultation asks about your health in two lists. One answer on the second list means we do not supply: "Gallbladder problems right now: gallstones causing pain, cholecystitis, or waiting for gallbladder surgery". Gallstones in the past, or stones found by chance that have never caused symptoms, go on the first list as "Gallbladder disease", which does not stop the consultation but marks your order for the pharmacist to review before anything is supplied. The health check before each reorder asks the second list every time, and the first list whenever you say your health has changed; a gallbladder problem answered there is flagged for your pharmacist to review before anything is sent, and if your order cannot be supplied you are refunded in full.

    This is our own rule, not a restriction in the licence: the Mounjaro product information lists one contraindication, an allergy to tirzepatide or any of its other ingredients, and its warnings say nothing about gallstones. We take the stricter line because gallbladder disease that is causing symptoms needs its own treatment first, and a medicine linked to gallbladder problems, with nausea and stomach pain of its own, would muddy the picture for the doctors treating it. Waiting for gallbladder surgery is part of that answer however far off the operation is, and any operation under a general anaesthetic or deep sedation within the next 7 days stops the consultation on its own. Once your gallbladder has been treated and your surgeon or GP is happy, you can start the consultation again. If you are moving to Solira from another provider, the consultation asks the same questions; our switching page explains how a switch works.

    Already a Solira patient? If you are told you have gallstones, message your pharmacist through your account before your next order. If you have the pain described below, get medical help first (the safety box at the end of this guide says when it is urgent), then let us know what you were told.

    Not started treatment yet? Check whether it's suitable for you in a few minutes. A GPhC-registered pharmacist reviews every assessment, and if they can't approve your order, you get a full refund.

    Check your eligibility

    Can you take Mounjaro after gallbladder removal?

    The UK product information places no restriction on taking Mounjaro after gallbladder removal, and our consultation does not exclude it: you tell us about the operation under "Gallbladder disease" and your pharmacist reviews it with the rest of your answers. The NHS puts it plainly: it is possible to lead a perfectly normal life without a gallbladder, because the organ stores and concentrates bile rather than making it, and your liver still produces bile to digest food.

    Three practical points. Mounjaro's very common stomach effects (nausea, diarrhoea, vomiting, constipation and stomach pain) are listed for everyone, with no separate figures for people without a gallbladder, and the NHS notes that some people who have had theirs removed get bloating and diarrhoea after certain foods, so if your digestion is already sensitive, tell your pharmacist and read our guide to Mounjaro side effects before you start. If the operation was recent, your surgical team's recovery advice comes first, and an operation under a general anaesthetic in the next 7 days stops our consultation until it is over. And stones can still be left in the bile ducts after surgery, which the NHS lists among the operation's possible complications, so new pain or yellowing after the operation is for your doctor, whatever you are taking.

    What are the symptoms of gallstones on Mounjaro?

    Most gallstones cause no symptoms at all; the sign to know is the pain, which the NHS calls biliary colic: severe, constant, in the middle of your tummy or just under your ribs on the right, lasting longer than 30 minutes and up to several hours, and it may make you feel sick or vomit. It comes when a stone blocks a bile duct. An inflamed gallbladder (acute cholecystitis) feels different: a sudden, sharp pain in the upper right of the tummy that spreads towards the right shoulder, is tender to touch, is worse when you breathe in deeply and does not go away within a few hours, sometimes with a high temperature, sweating, feeling or being sick, loss of appetite or yellowing of the skin and the whites of the eyes.

    The difficulty on Mounjaro is overlap. Nausea, vomiting and stomach pain are very common side effects, most of all in the first weeks and after each dose increase, and the MHRA has warned that the early signs of pancreatitis can be put down to those ordinary side effects. The same caution applies to the gallbladder. Ordinary Mounjaro stomach side effects are mostly mild or moderate and ease over time, and they are not a severe pain in one place that lasts for hours. A pain like that, or any pain with a fever or yellowing, is not something to wait out.

    If you think it is your gallbladder

    1. Do not wait it out. Tummy pain that lasts longer than 30 minutes needs an urgent GP appointment or a call to NHS 111, the NHS says.

    2. Call 999 or go to A&E for sudden, severe tummy pain, pain spreading to your back with being sick, a very high temperature or feeling hot, cold or shivery, or yellow skin or whites of the eyes. Do not drive yourself: ask someone to take you or call an ambulance.

    3. Say you take Mounjaro. Tell whoever treats you that you take tirzepatide, a GLP-1 medicine, and when your last dose was. The MHRA notes that a privately prescribed GLP-1 medicine may not be on your medical record, so nobody will know unless you say.

    4. Then tell your pharmacist. Stop your treatment while you are being assessed, as the safety box below says, and message us from your account once you know what is happening. Do not restart until your doctor and your pharmacist agree it is safe.

    How can you lower the risk of gallstones while losing weight?

    Lose weight steadily rather than as fast as you can. That is the NHS advice for lowering the risk of gallstones, and it fits how Mounjaro is meant to be used: a 2.5mg starting dose for 4 weeks, then 5mg, with any further step taken after at least 4 weeks on the current dose, each one a pharmacist decision based on how you are getting on. Stomach side effects are at their highest while the dose is going up, and faster weight loss is the gallstone risk the trials point to; our guide on when to increase your Mounjaro dose explains how we decide.

    Eat regularly, and keep fibre in your meals. The NHS lists a diet high in fat and low in fibre among the risk factors, and advises a healthy, balanced diet with fewer high-cholesterol foods rather than a very low-calorie plan; Mounjaro reduces appetite, so the risk is eating too little and too randomly rather than too much. Our guide on what to eat on Mounjaro has a pharmacist's practical plan. We suggest no supplement or tablet to prevent gallstones; if you have had them before, tell your GP and us.

    Does Wegovy cause gallstones too?

    Yes. The Wegovy product information (text revised September 2026) lists gallstones (cholelithiasis) as a common side effect, up to 1 in 10 people, and reports that in its clinical trials "cholelithiasis was reported in 1.6% and led to cholecystitis in 0.6% of patients treated with semaglutide 2.4 mg". Those were four 68-week trials in adults with a BMI of 30 or above, or 27 or above with a weight-related condition. The Wegovy table gives no separate cholecystitis grading and no placebo figure, so the two medicines' numbers are not a direct comparison. The warning signs and our rule are the same for Wegovy as for Mounjaro: we do not supply it to anyone with gallbladder problems right now, and a history of gallbladder disease is reviewed by the pharmacist. Our guides to Wegovy side effects and whether Wegovy is safe cover the rest of its safety profile, and Is Mounjaro safe? does the same for Mounjaro.

    When should you get urgent help?

    Stop your treatment and get urgent medical help for sudden pain in the upper right of your tummy, a fever, or yellowing of the skin or eyes, which can be signs of a gallbladder problem, and for severe, persistent stomach pain that spreads to your back, which can be a sign of pancreatitis. That is the safety advice every Solira weight-loss patient is given, word for word in the box below; the NHS thresholds for NHS 111 and 999 are in the steps above.

    Pancreatitis deserves its own mention, because a gallstone is one of its causes and because the MHRA strengthened its warnings in January 2026: acute pancreatitis is an uncommon side effect of GLP-1 medicines as a class, there have been reports of severe and fatal cases, treatment is stopped if it is suspected and never restarted if it is confirmed, and we do not supply Mounjaro or Wegovy to anyone who has had pancreatitis, whether a gallstone caused it or not.

    Switching from another provider?

    You may be able to carry on at your current dose. Upload proof of your current treatment during your consultation, and your pharmacist checks it before anything is supplied.

    When should you speak to your pharmacist or doctor?

    Stop your treatment and seek urgent medical help if you experience: severe, persistent stomach pain, especially spreading to your back, with or without vomiting. This can be a sign of pancreatitis. Sudden pain in the upper right of your tummy, fever, or yellowing of the skin or eyes: possible gallbladder problems. Sudden loss of vision, or loss of part of your field of vision: seek same-day eye assessment. Swelling of the face or lips, difficulty breathing, or a widespread rash: call 999.

    Seek advice promptly if you notice: signs of dehydration during vomiting or diarrhoea (dizziness, reduced urination, dry mouth): keep sipping fluids, as dehydration can affect your kidneys; palpitations or a racing heartbeat at rest; a new neck lump, swelling, or hoarseness. If you have type 2 diabetes and use insulin or a sulfonylurea, know the signs of low blood sugar (sweating, shaking, sudden hunger, confusion) and treat promptly.

    Before any operation: tell your surgical or anaesthetic team you take a GLP-1 medicine. It slows stomach emptying, which matters for anaesthesia.

    Tell your pharmacist about any gallstones or gallbladder disease, now or in the past, and about a gallbladder operation and when it was. If you are told you have gallstones while on treatment, message your pharmacist before your next order.

    Tummy pain that lasts longer than 30 minutes needs an urgent GP appointment or a call to NHS 111. Do not drive yourself to A&E: ask someone to take you, or call 999.

    Urgent help, genuine medicines and the official leaflets

    Frequently asked questions

    Yes. The UK product information for Mounjaro lists gallstones (cholelithiasis) as a common side effect in the weight-management trials, which means up to 1 in 10 people, and an inflamed gallbladder (cholecystitis) as uncommon, up to 1 in 100. In the pooled SURMOUNT-1, -2 and -3 trials, acute gallbladder problems affected 2.0% of people on tirzepatide and 1.6% of people on placebo, and the product information links them to greater weight loss.

    Common, which in the UK product information means at least 1 in 100 and up to 1 in 10 people. Counting everyone in the pooled SURMOUNT-1, -2 and -3 weight-management trials, gallstones were reported by 1.1% of people on tirzepatide and 1.0% on placebo, cholecystitis by 0.6% and 0.2%, and any acute gallbladder disease by 2.0% and 1.6%. Gallstones are also common in people who take no weight-loss medicine: the NHS says they affect more than 1 in 10 adults in the UK, most of whom never have symptoms.

    It depends on whether they are causing problems now. One answer in our consultation means we do not supply: "Gallbladder problems right now: gallstones causing pain, cholecystitis, or waiting for gallbladder surgery". Gallstones in the past, or stones found by chance that have never caused symptoms, do not rule you out on their own: you tell us about them under "Gallbladder disease" and a GPhC-registered pharmacist reviews your answers before anything is supplied. The UK product information places no restriction on gallstones; this is our own rule.

    The UK product information for Mounjaro places no restriction on people who have had their gallbladder removed, and our consultation does not exclude it: you tell us about the operation under "Gallbladder disease" and your pharmacist reviews it with the rest of your answers. The NHS says it is possible to lead a normal life without a gallbladder, because your liver still produces bile to digest food. If the operation was recent, your surgical team's recovery advice comes first.

    As far as the UK product information is concerned, yes: it places no restriction on people without a gallbladder. The NHS describes the gallbladder as useful but not essential, because the liver still produces bile. Some people without a gallbladder get bloating or diarrhoea after certain foods, and Mounjaro's own very common side effects include nausea, diarrhoea and stomach pain, so tell your pharmacist if your digestion is troublesome once you start. A GPhC-registered pharmacist reviews every consultation.

    The same as gallstones from any cause. The NHS describes the pain, called biliary colic, as severe and constant, in the middle of your tummy or just under your ribs on the right, lasting longer than 30 minutes and up to several hours, sometimes with feeling or being sick. An inflamed gallbladder causes a sudden, sharp pain in the upper right of the tummy that spreads towards the right shoulder and does not go away within a few hours, sometimes with a high temperature. Tummy pain lasting longer than 30 minutes needs an urgent GP appointment or NHS 111; sudden severe pain, pain spreading to your back with vomiting, a very high temperature, or yellow skin or eyes needs 999 or A&E.

    The NHS lists losing weight quickly among the things that make gallstones more likely, alongside being over 40, being a woman, living with obesity, a diet high in fat and low in fibre, and conditions such as diabetes or Crohn's disease. Its acute cholecystitis page says low-calorie rapid weight loss diets can disrupt bile chemistry and increase the risk, and that a more gradual weight loss plan is better. The Mounjaro product information gives no mechanism; it says the gallbladder events in its weight-management trials were linked to greater weight loss.

    Yes. The Wegovy product information lists gallstones (cholelithiasis) as a common side effect, up to 1 in 10 people. In its weight-management trials, gallstones were reported by 1.6% of people on semaglutide 2.4mg and led to cholecystitis in 0.6%. The same warning signs apply, and the same rule at Solira: we do not supply Wegovy to anyone with gallbladder problems right now, and a history of gallbladder disease is reviewed by the pharmacist.

    Lose weight steadily rather than as fast as possible. The NHS advises against low-calorie rapid weight loss diets because they can increase the risk of gallstones, recommends a healthy, balanced diet with fewer high-cholesterol foods, and lists a diet high in fat and low in fibre among the risk factors. On Mounjaro that means keeping to the dose steps your pharmacist agrees rather than moving up early, and not adding a crash diet on top of the medicine. We do not suggest any supplement or tablet for preventing gallstones; if you have had them before, tell your pharmacist and your GP.

    Keep reading

    Ready to start?

    Start your free consultation with a GPhC-registered pharmacist.

    Begin consultation

    Follow us on Instagram (opens Instagram in a new tab)